Oxford Biomedica (LON:OXB) Stock Price Crosses Above Fifty Day Moving Average – Should You Sell?

Oxford Biomedica plc (LON:OXB)’s share price passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 421.03 ($5.27) and traded as high as GBX 427.50 ($5.35). Oxford Biomedica shares last traded at GBX 423 ($5.29), with a volume of 114,411 shares trading hands.

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft lifted their target price on shares of Oxford Biomedica from GBX 250 ($3.13) to GBX 380 ($4.75) and gave the company a “hold” rating in a research note on Tuesday, September 24th.

Oxford Biomedica Trading Down 0.5 %

The firm has a market capitalization of £443.57 million, a price-to-earnings ratio of -292.36 and a beta of 1.09. The company has a fifty day moving average price of GBX 421.03 and a 200-day moving average price of GBX 376.04. The company has a current ratio of 2.35, a quick ratio of 1.67 and a debt-to-equity ratio of 154.88.

Oxford Biomedica Company Profile

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.